bgt-226 pi3k Pages on BioPortfolio:

BioPortfolio - BGT226
Recent Search Terms used to find this page: mTOR PI3K BGT226 patent | 3-kinase serono patent | 3-kinase serono patent | patents serono 3-kinase | BGT-226 . ...
http://www.bioportfolio.com/search/BGT226.html...

BioPortfolio - bgt-226 pi3k
bgt-226 pi3k - BioPortfolio. ... Recent Search Terms used to find this page: mTOR PI3K BGT226 patent | 3-kinase serono patent | 3-kinase serono patent ...
http://www.bioportfolio.com/search/bgt-226_pi3k.html...

BioPortfolio - PI3K
PI3K inhibitor BGT226 specifically inhibits PIK3 in the PI3K/AKT kinase (or . ... bgt-226 pi3k - BioPortfolio. ... Recent Search Terms used to find this ...
http://www.bioportfolio.com/search/PI3K.html...

BioPortfolio - PI3 - peptidase inhibitor 3, skin-derived (SKALP)
PI3 Kinase Class III Antibody detects endogenous levels of total PI3K class ... lipid kinase patent p110 | elafin 2008 | BGT226 patent | bgt-226 pi3k | . ...
http://www.bioportfolio.com/gene/5266-PI3.html...

Results from other life science and pharmaceutical sites:

BioPortfolio - BGT226
Recent Search Terms used to find this page: mTOR PI3K BGT226 patent ... PI3K inhibitor BGT226 specifically inhibits PIK3 in the PI3K/AKT kinase (or . ...
http://www.bioportfolio.com/search/BGT226.html...

Oncogene - PI3K pathway alterations in cancer: variations on a theme
Two Novartis compounds, BGT226 and the pan-PI3K/mTOR inhibitor, NVP-BEZ235, are in ongoing trials as monotherapy for breast and other solid tumors and are ...
http://www.nature.com/onc/journal/v27/n41/full/onc2008245a.h...

CLINICAL STUDIES
BGT226, is a PI3K/mTOR dual kinase inhibitor. Oral BGT226 is. given once-a day three times a week in patients with advanced ...
http://www.ctrc.net/forms/pdf/clinicalStudiesWinter08.pdf...

NCI Drug Dictionary - National Cancer Institute
A phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. PI3K inhibitor BGT226 specifically inhibits PIK3 in the PI3K/AKT ...
http://www.nci.nih.gov/templates/drugdictionary.aspx?expand=...

Self-Activating Viridin (SAV) Pro-drug for Ovarian Cancer
Wortmannin inhibits PI3K. 1/2-life too short; Highly toxic in humans. Self- Activating Viridin (SAV) ... BGT226. Novartis. oral. BEZ235A. Novartis ...
http://www.hbs.edu/units/tom/conferences/docs/SAV%20Prodrug....

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.